Downregulated miR-33b is a novel predictor associated with disease progression and poor prognosis in multiple myeloma-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Downregulated miR-33b is a novel predictor associated with disease progression and poor prognosis in multiple myeloma

Published:2015-07 Issue:7 Volume:39 Page:793-799
ISSN:0145-2126
Container-title:Leukemia Research
language:en
Short-container-title:Leukemia Research

Author:

Li Fei^ORCID,Hao Mu,Feng Xiaoyan,Zang Meirong,Qin Yu,Yi Shuhua,Li Zengjun,Xu Yan,Zhou Lili,Sui Weiwei,Deng Shuhui,Zou Dehui,Zhan Fenghuang,Qiu Lugui

Funder

Science and Technology Infrastructure Program

National Natural Science Foundation of China

National Public Health Grand Research Foundation

Science and Technology Support Program of Jiangxi Province

Publisher

Elsevier BV

Subject

Cancer Research,Oncology,Hematology

Reference34 articles.

1. Prognostic and therapeutic significance of myeloma genetics and gene expression profiling;Stewart;J Clin Oncol,2005

2. Consensus recommendations for risk stratification in multiple myeloma: report of the International Myeloma Workshop Consensus Panel 2;Munshi;Blood,2011

3. Most mammalian mRNAs are conserved targets of microRNAs;Friedman;Genome Res,2009

4. Molecular biology: the expanding world of small RNAs;Grosshans;Nature,2008

5. The role of microRNAs in normal and malignant hematopoiesis;Vasilatou;Eur J Haematol,2010

Cited by 22 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Highlighting the role of long non-coding RNA (LncRNA) in multiple myeloma (MM) pathogenesis and response to therapy;Medical Oncology;2024-06-07

2. miR-33b in human cancer: Mechanistic and clinical perspectives;Biomedicine & Pharmacotherapy;2023-05

3. Non-coding RNAs and exosomal ncRNAs in multiple myeloma: An emphasis on molecular pathways;European Journal of Pharmacology;2023-02

4. Comprehensive small RNA-sequencing of primary myeloma cells identifies miR-105-5p as a predictor of patient survival;British Journal of Cancer;2022-11-29

5. Role of ncRNA in multiple myeloma;Biomarkers in Medicine;2022-11

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3